000 01302 a2200349 4500
005 20250513081435.0
264 0 _c19930511
008 199305s 0 0 eng d
022 _a0028-3878
024 7 _a10.1212/wnl.43.4.662
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPaty, D W
245 0 0 _aInterferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group.
_h[electronic resource]
260 _bNeurology
_cApr 1993
300 _a662-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aInterferon-beta
_xtherapeutic use
650 0 4 _aMagnetic Resonance Imaging
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aMultiple Sclerosis
_xdiagnosis
650 0 4 _aRecurrence
650 0 4 _aTreatment Outcome
700 1 _aLi, D K
773 0 _tNeurology
_gvol. 43
_gno. 4
_gp. 662-7
856 4 0 _uhttps://doi.org/10.1212/wnl.43.4.662
_zAvailable from publisher's website
999 _c8468588
_d8468588